Skip to content

NRXP

NRX Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.32
−2.06%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
22.50x
P/S forward
1.69x

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
-845.54x
Price / sales
42.35x
Price / cash flow
-7.27x

Enterprise value

Enterprise value
$118.3M
EV / sales
34.86x
EV / EBITDA
-5.39x
EV / EBIT
-5.93x
Market cap
$143.7M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026